BHVN logo

Biohaven Pharmaceutical Holding (BHVN) Interest Expense

Annual Interest Expense

N/A

31 December 2023

BHVN Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

30 September 2024

BHVN Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

30 September 2024

BHVN TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BHVN Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

BHVN Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Biohaven Pharmaceutical Holding Interest Expense History

DateAnnualQuarterlyTTM
June 2022
-
$43.24 M(+1.9%)
$160.57 M(+8.7%)
Mar 2022
-
$42.45 M(+0.6%)
$147.71 M(+9.9%)
Dec 2021
$134.45 M(+57.3%)
-
-
Dec 2021
-
$42.21 M(+29.2%)
$134.45 M(+11.0%)
Sept 2021
-
$32.68 M(+7.6%)
$121.09 M(+7.8%)
June 2021
-
$30.38 M(+4.1%)
$112.28 M(+11.6%)
Mar 2021
-
$29.18 M(+1.2%)
$100.64 M(+17.7%)
Dec 2020
$85.50 M(+117.6%)
-
-
Dec 2020
-
$28.85 M(+20.8%)
$85.50 M(+25.1%)
Sept 2020
-
$23.87 M(+27.4%)
$68.32 M(+21.7%)
June 2020
-
$18.73 M(+33.4%)
$56.14 M(+20.7%)
Mar 2020
-
$14.04 M(+20.3%)
$46.52 M(+18.4%)
Dec 2019
$39.29 M
-
-
Dec 2019
-
$11.67 M(-0.1%)
$39.29 M(+18.3%)
Sept 2019
-
$11.69 M(+28.3%)
$33.21 M(+22.3%)
June 2019
-
$9.11 M(+33.6%)
$27.15 M(+46.4%)
DateAnnualQuarterlyTTM
Mar 2019
-
$6.82 M(+21.9%)
$18.54 M(+58.1%)
Dec 2018
$11.73 M(>+9900.0%)
-
-
Dec 2018
-
$5.59 M(-0.7%)
$11.73 M(+124.3%)
Sept 2018
-
$5.63 M(+1024.4%)
$5.23 M(-3249.4%)
June 2018
-
$501.00 K(>+9900.0%)
-$166.00 K(-45.6%)
Mar 2018
-
$0.00(-100.0%)
-$305.00 K(<-9900.0%)
Dec 2017
$0.00(-100.0%)
-
-
Dec 2017
-
-$906.00 K(-479.1%)
$0.00(-100.0%)
Sept 2017
-
$239.00 K(-34.0%)
$1.20 M(+13.9%)
June 2017
-
$362.00 K(+18.7%)
$1.05 M(+52.5%)
Mar 2017
-
$305.00 K(+4.5%)
$690.00 K(+79.2%)
Dec 2016
$385.00 K(>+9900.0%)
-
-
Dec 2016
-
$292.00 K(+214.0%)
$385.00 K(+314.0%)
Sept 2016
-
$93.00 K(>+9900.0%)
$93.00 K(>+9900.0%)
June 2016
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2016
-
$0.00
$0.00
Dec 2015
$0.00
-
-

FAQ

  • What is the all time high annual interest expense for Biohaven Pharmaceutical Holding?
  • What is the all time high quarterly interest expense for Biohaven Pharmaceutical Holding?
  • What is the all time high TTM interest expense for Biohaven Pharmaceutical Holding?

What is the all time high annual interest expense for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual interest expense is $134.45 M

What is the all time high quarterly interest expense for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly interest expense is $43.24 M

What is the all time high TTM interest expense for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high TTM interest expense is $160.57 M